Who owns Aclaris Therapeutics?
- Ticker: ACRS
- CUSIP Number: 00461u105
Tip: Access positions for across all investors
Analyze quarterly positions in Aclaris Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aclaris Therapeutics stock
Who bought or sold Aclaris Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 14M | $27M | 0% | Sep 2025 |
|
| Vivo Capital | 8.9M | $17M | 0% | Sep 2025 |
|
| Vanguard Group | 6.5M | $12M | -2% | Sep 2025 |
|
| BlackRock | 5.7M | $11M | 3% | Sep 2025 |
|
| Adage Capital Partners GP | 5.3M | $10M | -45% | Sep 2025 |
|
| Rock Springs Capital Management | 4.6M | $8.8M | -3% | Sep 2025 |
|
| Decheng Capital | 4.0M | $7.7M | 0% | Sep 2025 |
|
| Morgan Stanley | 3.5M | $5.0M | 100% | Jun 2025 |
|
| Geode Capital Management | 2.4M | $4.5M | -3% | Sep 2025 |
|
| D. E. Shaw & Co | 2.4M | $4.5M | -15% | Sep 2025 |
|
| Acadian Asset Management | 2.3M | $4.4M | -4% | Sep 2025 |
|
| Marshall Wace | 1.7M | $3.3M | -25% | Sep 2025 |
|
| Renaissance Technologies | 1.6M | $3.1M | 11% | Sep 2025 |
|
| Palo Alto Investors | 1.6M | $3.0M | 13% | Sep 2025 |
|
| Millennium Management | 1.6M | $3.0M | -59% | Sep 2025 |
|
| Logos Global Management | 1.5M | $2.9M | -19% | Sep 2025 |
|
| Citadel Advisors | 1.4M | $2.7M | 25% | Sep 2025 |
|
| Ameriprise Financial | 1.3M | $2.4M | 100% | Sep 2025 |
|
| Bollard | 1.2M | $2.3M | -9% | Sep 2025 |
|
| State Street Corporation | 1.1M | $2.1M | 11% | Sep 2025 |
|
| Connor, Clark & Lunn Investment Management | 1.1M | $2.0M | 34% | Sep 2025 |
|
| Aldebaran Capital | 988k | $1.9M | -1% | Sep 2025 |
|
| Goldman Sachs Group | 956k | $1.8M | 72% | Sep 2025 |
|
| Deutsche Bank Aktiengesellschaft | 923k | $1.8M | -8% | Sep 2025 |
|
| Jpmorgan Chase & Co | 759k | $1.4M | 52% | Sep 2025 |
|
| Three Bridge Wealth Advisors | 715k | $1.4M | 100% | Sep 2025 |
|
| Northern Trust | 701k | $1.3M | -9% | Sep 2025 |
|
| Qube Research & Technologies | 545k | $1.0M | 7% | Sep 2025 |
|
| Aisling Capital Management | 435k | $826k | 0% | Sep 2025 |
|
| Bridgeway Capital Management | 393k | $747k | -11% | Sep 2025 |
|
| ADAR1 Capital Management | 374k | $710k | 100% | Sep 2025 |
|
| Two Sigma Investments | 368k | $699k | -51% | Sep 2025 |
|
| Two Sigma Advisers | 350k | $665k | -54% | Sep 2025 |
|
| HighTower Advisors | 309k | $588k | -4% | Sep 2025 |
|
| Raymond James Financial | 284k | $539k | 2% | Sep 2025 |
|
| Charles Schwab Investment Management | 242k | $460k | -7% | Sep 2025 |
|
| Nuveen | 238k | $452k | 0% | Sep 2025 |
|
| Bank of New York Mellon | 220k | $418k | 2% | Sep 2025 |
|
| Stonepine Capital Management | 193k | $367k | -61% | Sep 2025 |
|
| Dimensional Fund Advisors | 164k | $312k | -21% | Sep 2025 |
|
| Invesco | 163k | $309k | 20% | Sep 2025 |
|
| Assenagon Asset Management | 155k | $294k | -16% | Sep 2025 |
|
| Barclays | 123k | $235k | -21% | Sep 2025 |
|
| UBS Group | 105k | $200k | -31% | Sep 2025 |
|
| Rhumbline Advisers | 91k | $173k | 7% | Sep 2025 |
|
| Jane Street | 73k | $139k | 100% | Sep 2025 |
|
| Wells Fargo & Company | 68k | $129k | 8% | Sep 2025 |
|
| Algert Coldiron Investors | 66k | $125k | 65% | Sep 2025 |
|
| XTX Topco | 64k | $122k | 167% | Sep 2025 |
|
| New York State Common Retirement Fund | 48k | $92k | -25% | Sep 2025 |
|
| PanAgora Asset Management | 46k | $87k | 100% | Sep 2025 |
|
| Mirae Asset Global Etfs Holdings | 43k | $81k | -14% | Sep 2025 |
|
| Cambridge Investment Research Advisors | 42k | $80k | 0% | Sep 2025 |
|
| FMR | 40k | $77k | -91% | Sep 2025 |
|
| Intech Investment Management | 39k | $74k | -13% | Sep 2025 |
|
| Oxford Asset Management | 36k | $69k | 100% | Sep 2025 |
|
| Susquehanna International | 36k | $69k | -70% | Sep 2025 |
|
| MetLife Investment Advisors | 35k | $67k | -37% | Sep 2025 |
|
| AQR Capital Management | 35k | $66k | 100% | Sep 2025 |
|
| Manufacturers Life Insurance Company | 34k | $64k | -2% | Sep 2025 |
|
| Velan Capital Investment Management | 33k | $62k | 0% | Sep 2025 |
|
| American Century Companies | 32k | $60k | 100% | Sep 2025 |
|
| Royal Bank of Canada | 28k | $54k | 236% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 27k | $51k | 59% | Sep 2025 |
|
| Vontobel Holding | 26k | $49k | 0% | Sep 2025 |
|
| SG Americas Securities | 22k | $42k | -59% | Sep 2025 |
|
| Police & Firemen's Retirement System of New Jersey | 20k | $37k | 100% | Sep 2025 |
|
| Engineers Gate Manager | 18k | $34k | 1% | Sep 2025 |
|
| CRA Financial Services | 18k | $34k | 0% | Sep 2025 |
|
| Ing Investment Management | 17k | $33k | -36% | Sep 2025 |
|
| Mariner Wealth Advisors | 16k | $31k | -23% | Sep 2025 |
|
| Alliancebernstein | 15k | $29k | 0% | Sep 2025 |
|
| ProShare Advisors | 15k | $28k | -20% | Sep 2025 |
|
| Axq Capital | 14k | $27k | 100% | Sep 2025 |
|
| Neuberger Berman Group | 13k | $24k | 0% | Sep 2025 |
|
| Cibc World Markets | 11k | $16k | 100% | Jun 2025 |
|
| Leucadia National Corporation | 11k | $21k | 0% | Sep 2025 |
|
| Victory Capital Management | 11k | $20k | -3% | Sep 2025 |
|
| Two Sigma Securities | 11k | $20k | 100% | Sep 2025 |
|
| Mercer Global Advisors | 11k | $20k | 2% | Sep 2025 |
|
| Russell Investments | 9.6k | $18k | 1195% | Sep 2025 |
|
| Summit Investment Advisors | 9.3k | $18k | 0% | Sep 2025 |
|
| Legal & General Group | 8.2k | $16k | 0% | Sep 2025 |
|
| Tower Research Capital | 6.5k | $12k | 100% | Sep 2025 |
|
| Sterling Capital Management | 6.0k | $11k | 144% | Sep 2025 |
|
| California State Teachers Retirement System | 5.7k | $11k | 0% | Sep 2025 |
|
| Amalgamated Bank | 3.1k | $6.0k | 0% | Sep 2025 |
|
| Pnc Financial Services | 2.0k | $3.9k | 100% | Sep 2025 |
|
| Group One Trading | 1.7k | $3.3k | -29% | Sep 2025 |
|
| Advisor Group Holdings | 730.00 | $1.4k | 0% | Sep 2025 |
|
| Northwestern Mutual Wealth Management Company | 500.00 | $950.000000 | 0% | Sep 2025 |
|
| EverSource Wealth Advisors | 458.00 | $870.016800 | 0% | Sep 2025 |
|
| Capital Advisors | 454.00 | $999.980400 | 0% | Sep 2025 |
|
| SRS Capital Advisors | 447.00 | $848.987100 | 100% | Sep 2025 |
|
| NISA Investment Advisors | 318.00 | $604.009200 | 0% | Sep 2025 |
|
| CWM | 275.00 | $1.0k | 100% | Sep 2025 |
|
| SBI Securities | 239.00 | $454.004400 | -10% | Sep 2025 |
|
| Truvestments Capital | 150.00 | $285.000000 | 0% | Sep 2025 |
|
| Farther Finance Advisors | 99.00 | $188.001000 | 0% | Sep 2025 |
|
| Hartland & Co | 1.00 | $2.000000 | 100% | Sep 2025 |
|
Who sold out of Aclaris Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Cantor Fitzgerald, L. P. | Jun 2025 | 451k | $641k |
| Squarepoint Ops | Jun 2025 | 391k | $555k |
| GSA Capital Partners | Jun 2025 | 47k | $67k |
| Marex Group | Jun 2025 | 14k | $20k |
| Simplex Trading | Jun 2025 | 1.3k | $999.996000 |
| Caitong International Asset Management | Jun 2025 | 1.3k | $1.8k |
| Federated Investors | Jun 2025 | 902.00 | $1.3k |